Results 21 to 30 of about 3,182,211 (266)

Prevalence, Awareness, and Treatment of Hepatitis C Virus Infection in South Korea: Evidence from the Korea National Health and Nutrition Examination Survey

open access: yesGut and Liver, 2020
Background/Aims: This study aimed to investigate the epidemiology of hepatitis C virus (HCV) infection in the Korean general population and the awareness and treatment status of HCV infection among anti-HCV-positive persons.
Kyung-Ah Kim, June Sung Lee
doaj   +1 more source

Structure-activity relationships of fluorene compounds inhibiting HCV variants [PDF]

open access: yes, 2020
Approximately 71 million people suffer from hepatitis C virus (HCV) infection worldwide. Persistent HCV infection causes liver diseases such as chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma, resulting in approximately 400,000 deaths ...
Gadhe, Changdev G.   +10 more
core   +1 more source

Frequency of active HCV infection among anti-HCV positive patients in selected districts of Khyber Pakhtunkhwa, Pakistan [PDF]

open access: yesJournal of Microbiology and Infectious Diseases, 2013
Objective: The objective of this study was to determine frequency of active HCV infection among confirmed anti-HCV positive subjects of KPK in order to help the infected subjects decide about anti-viral treatment options.Methods: Blood samples (3075 ...
Sajid Ali   +3 more
doaj   +2 more sources

Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection. [PDF]

open access: yesPLoS ONE, 2014
The aim of this study is to explore the prevalence of hepatitis C virus (HCV) infection among injection drug users (IDUs) with and without human immunodeficiency virus (HIV) infection in southern Taiwan.
Meng-Hsuan Hsieh   +13 more
doaj   +1 more source

Multicenter evaluation of the new Alinity s anti-HCV II assay for routine hepatitis C virus blood screening

open access: yesJournal of Clinical Virology Plus, 2023
Background: Anti-HCV immunoassays remain the primary serologic test for HCV screening among blood donors. Since 1990s, Anti-HCV assays have evolved and those currently available detect infection earlier and have improved sensitivity and specificity ...
Wai-Chiu Tsoi   +6 more
doaj   +1 more source

A single site study to investigate the current prevalence of anti‐hepatitis C virus antibody among substance use disorder patients in Hiroshima—Insufficient testing and diagnosis

open access: yesNeuropsychopharmacology Reports, 2023
Aims Hepatitis C virus (HCV) infection among drug users presents an important public health problem; however, little recognition and few approaches to address this issue in Japan.
Ariyuki Kagaya   +4 more
doaj   +1 more source

Incidence, prevalence, and clinical course of hepatitis C following liver transplantation [PDF]

open access: yes, 1992
Hepatitis C virus (HCV) is the agent responsible for posttransfusion hepatitis. The incidence, timing, and clinical course of HCV positive hepatitis in liver transplant recipients are unknown.
A.Jake Demetris   +35 more
core   +1 more source

Anti HCV seropozitif kişilerde moleküler HCV RNA test sonuçlarının değerlendirilmesi

open access: yesTurkish Journal of Family Practice, 2013
Amaç: Bu araştırmada, Anti HCV pozitif kişilerin HCV RNA viral yük miktarları incelenerek, akut enfeksiyon sonrası iyileşme, kronikleşme, hastaların tedavi yanıtları ve bunların cinsiyet ile iliflkisinin değerlendirilmesi amaçlanmıştır.
Cem Çelik   +4 more
doaj   +1 more source

Prevalence of Anti-HCV Antibody Among the General Population in Mainland China Between 1991 and 2015: A Systematic Review and Meta-analysis

open access: yesOpen Forum Infectious Diseases, 2019
Our study aims to estimate the burden of hepatitis C virus (HCV) infection among the general population in Mainland China. We searched 4 databases for studies of the prevalence of anti-HCV antibody among the general population.
Yuhua Gao   +6 more
semanticscholar   +1 more source

Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries

open access: yesBMC Infectious Diseases, 2018
BackgroundIncreasing the proportion diagnosed with and on treatment for chronic hepatitis C (CHC) is key to the elimination of hepatitis C in Europe. This study contributes to secondary prevention planning in the European Union/European Economic Area (EU/
A. Falla   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy